PHAEDRA HOCKMAN: Open Payments
NPI 1659008548 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,589 in 143 payments from 20 companies in 2025. Trend: 2023 $457 · 2024 $988 · 2025 $2,589
Food & beverage: $2,489Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $831 |
| Janssen Biotech, Inc. | 14 | $434 |
| Galderma Laboratories, L.P. | 23 | $247 |
| UCB, Inc. | 10 | $217 |
| Organon LLC | 17 | $202 |
| GENZYME CORPORATION | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| LEO Pharma Inc. | 3 | $58 |
Products named: RINVOQ, TREMFYA, SKYRIZI, NEMLUVIO, Bimzelx, DUPIXENT, Rhapsido, Sotyktu.
Industry payments across CO — which companies pay providers there.
